| Code | 1540B | ||||||||||
| MA number | EU/1/14/934/004 | ||||||||||
| Product Form: | sol inj 6x125 µg/0,5 ml (striek.inj.napl.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Biogen Netherlands B.V., Netherland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 18.07.2014 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC interferóny final 25 8 2014.pdf
|
| Safety feature | Yes |
| Data update: | 18.02.2022 |
